Investigational Drug Information for Psilocybin
✉ Email this page to a colleague
What is the development status for investigational drug Psilocybin?
Psilocybin is an investigational drug.
There have been 143 clinical trials for Psilocybin.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2022.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Disease. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and COMPASS Pathways.
There are seven hundred and twenty-six US patents protecting this investigational drug and zero international patents.
Summary for Psilocybin
| US Patents | 726 |
| International Patents | 2,399 |
| US Patent Applications | 2,063 |
| WIPO Patent Applications | 674 |
| Japanese Patent Applications | 25 |
| Clinical Trial Progress | Phase 2 (2022-11-01) |
| Vendors | 13 |
Recent Clinical Trials for Psilocybin
| Title | Sponsor | Phase |
|---|---|---|
| Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder | Johns Hopkins University | Phase 2 |
| Safety Profile of Psilocybin for Cocaine Use Disorder | University of California, Los Angeles | Early Phase 1 |
| A Randomized Neuroimaging Trial of Psilocybin in Depression | Sunnybrook Health Sciences Centre | Phase 2 |
Clinical Trial Summary for Psilocybin
Top disease conditions for Psilocybin
Top clinical trial sponsors for Psilocybin
US Patents for Psilocybin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Psilocybin | ⤷ Sign Up | Devices and methods for continuous analyte monitoring | DexCom, Inc. (San Diego, CA) | ⤷ Sign Up |
| Psilocybin | ⤷ Sign Up | Devices and methods for continuous analyte monitoring | DexCom, Inc. (San Diego, CA) | ⤷ Sign Up |
| Psilocybin | ⤷ Sign Up | Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods | DexCom, Inc. (San Diego, CA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Psilocybin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Psilocybin | Denmark | DK3069279 | 2033-11-14 | ⤷ Sign Up |
| Psilocybin | European Patent Office | EP3069279 | 2033-11-14 | ⤷ Sign Up |
| Psilocybin | European Patent Office | EP3796332 | 2033-11-14 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
